Neriforte (Diflucortolone Valerate)

Diflucortolone Valerate, the active ingredient in Neriforte, is a corticosteroid presented as a topical formulation for cutaneous use. It delivers anti‑inflammatory and antiallergic effects for the treatment of various dermatologic conditions such as eczema, psoriasis and allergic dermatitis in both adults and children.

GNH USA supplies Neriforte as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product is manufactured in the European Union and is available by prescription only. It complies with EU pharmacovigilance standards and is distributed to global markets under strict quality controls.

Diflucortolone Valerate is a potent topical corticosteroid used to manage inflammatory skin disorders.

Eczema: reduces inflammation, redness and itching associated with atopic eczema. Psoriasis: decreases plaque formation and scaling in plaque psoriasis. Allergic contact dermatitis: alleviates allergic reaction symptoms and skin irritation. Seborrheic dermatitis: controls inflammation and flaking in affected areas.

Topical application of Diflucortolone Valerate may be associated with local and systemic adverse reactions.

Common Side Effects: - Burning or stinging sensation at the application site. - Skin dryness or peeling. - Mild itching or irritation.

Serious or Rare Side Effects: - Skin atrophy or thinning with prolonged use. - Telangiectasia (visible small blood vessels). - Secondary bacterial, fungal or viral infection. - Systemic adrenal suppression (rare with extensive use).

When using Diflucortolone Valerate, several precautions should be observed to minimize risks.

Duration of therapy: limit use to the shortest effective period as advised by a healthcare professional. Occlusive dressings: avoid applying under airtight bandages unless directed, as this can increase absorption. Pregnancy and lactation: use only if clearly needed and prescribed after risk‑benefit assessment. Skin integrity: do not apply to infected, broken or ulcerated skin without medical guidance. Store at room temperature: keep in the original packaging, protect from moisture and light.

Diflucortolone Valerate can interact with other medications or substances that affect corticosteroid activity or skin absorption.

Major Interactions (Avoid): - Systemic corticosteroids: concurrent use may enhance systemic glucocorticoid effects and increase risk of adrenal suppression. - CYP3A4 inhibitors (e.g., ketoconazole): may raise systemic levels when large skin areas are treated.

Moderate Interactions (Monitor Closely): - Antiviral or antifungal topical agents: may alter local skin barrier and affect absorption. - Occlusive dressings or moisturizers: can increase drug penetration, requiring monitoring for side effects. - Topical non‑steroidal anti‑inflammatory drugs: combined use may increase local irritation.